Apr 25 |
20 Countries with the Highest Rates of Stomach Cancer in the World
|
Apr 24 |
Global Oncology Innovator BeiGene Highlights New Data across Hematology and Solid Tumor Portfolio at 2024 ASCO Annual Meeting
|
Apr 24 |
Evaluating BeiGene: Insights From 6 Financial Analysts
|
Apr 23 |
EU regulators approve BeiGene's tislelizumab for lung cancer
|
Apr 23 |
With 42% ownership of the shares, BeiGene, Ltd. (NASDAQ:BGNE) is heavily dominated by institutional owners
|
Apr 23 |
BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer
|
Mar 27 |
Shareholders in BeiGene (NASDAQ:BGNE) have lost 54%, as stock drops 8.5% this past week
|
Mar 22 |
Lululemon Issues Weak Outlook, Joins Nike And Other Big Stocks Moving Lower In Friday's Pre-Market Session
|
Mar 17 |
30 Biggest Biotechnology Companies in the World
|
Mar 14 |
BeiGene gets FDA approval for esophageal cancer drug Tevimbra
|